Cancer Therapy
A section of Cancers (ISSN 2072-6694).
Section Information
In the last decades, cancer therapies have substantially improved cancer care and patients’ survival. The introduction of targeted therapies had a major impact on the management of cancer. However, millions of people still die from cancer every year and cancer drug resistance remains the Achilles' heel of cancer chemotherapeutics. Thanks to our increasing knowledge and understanding of the pathology, new cancer cells phenotypes and drug targets have emerged in the last years. The role of the tumor microenvironment in cancer promotion and progression as well as the plastic and dynamic nature of the disease have been unraveled and now pave the way to the development of new and innovative therapeutic strategies. In this section of Cancers, we aim at rapidly publishing contributions on all aspects of Cancer Therapy. We encourage the submission of manuscripts providing new and innovative therapeutic approaches as well as papers describing technologies and models developed for the discovery and the delivery of anticancer drugs. Systematic and perspective reviews are also welcome. Topics include, but are not limited to:
- Cancer therapeutics
- Targeted therapy
- Drug discovery
- Drug repurposing
- Structure-based design
- Target-based design
- Tumor drug delivery
- Tumor drug distribution
- Drug resistance
- Precision medicine
- Gain/loss of function screening
- Cancer cell plasticity
- Cancer cell metabolism
- Cell cycle checkpoint
- DNA repair
- Tumor-microenvironment interactions
- Extracellular vesicles
- Tumor heterogeneity
- Combination therapies
- Adaptive therapy
- Rechallenge therapy
- Radiotherapy
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Advances of Particle Therapy in Prostate Cancer (Deadline: 10 September 2024)
- Advances in Hereditary Colorectal Cancer: Diagnosis and Treatment (Deadline: 12 September 2024)
- Novel Combination Therapies for Acute Leukemia (Deadline: 15 September 2024)
- Advances in Particle Therapy for Cancer Treatment and Research (Deadline: 15 September 2024)
- Surgical Approach to Primary Lung Cancer and Metastatic Solid Tumors Involving the Lung (Deadline: 15 September 2024)
- Advances in Cancer Therapeutics (Deadline: 20 September 2024)
- Advances in Melanoma Treatments: Molecular Targeted Therapies, Immunotherapies and Vaccines (Deadline: 20 September 2024)
- Neoadjuvant Therapy of Breast Cancer (Deadline: 20 September 2024)
- Advances in Surgery of Head and Neck Squamous Cell Carcinoma (Deadline: 20 September 2024)
- Research Progress of Prostate Cancer Stem Cell Inhibitors (Deadline: 20 September 2024)
- Radiochemotherapy, Radioimmunotherapy and Targeted Therapy in Locally Advanced and Metastatic Head and Neck Cancer (Deadline: 20 September 2024)
- Study and Treatment of Oral Squamous Cell Carcinoma (Volume II) (Deadline: 20 September 2024)
- Interdisciplinary Approach to Soft Tissue Sarcoma Care: Bridging Gaps for Better Outcomes (Deadline: 20 September 2024)
- Recent Research on Immunotherapy in Ovarian Cancer (Deadline: 25 September 2024)
- Advances in the Management of Pelvic Tumors (Deadline: 25 September 2024)
- Hot Topics in Neuro-Oncology (Deadline: 27 September 2024)
- Research on Fluorescence-Guided Surgery in Cancer Treatment (Deadline: 27 September 2024)
- Ibrutinib in Chronic Lymphocytic Leukemia (Deadline: 30 September 2024)
- New Insights into Esophageal Cancer Chemotherapy (Deadline: 30 September 2024)
- BRCA Associated Cancers: Latest Predictive and Therapeutic Approaches (Deadline: 30 September 2024)
- Recent Advances in Ovarian Cancer Surgery (Deadline: 30 September 2024)
- The Role of Aromatase Inhibitors in Breast Cancer Treatment (Deadline: 30 September 2024)
- Modern Pathology, Artificial Intelligence and Personalized Therapy in Gastrointestinal Cancer (Deadline: 30 September 2024)
- Circadian Rhythms, Cancers and Chronotherapy (Deadline: 30 September 2024)
- Radiotherapy for Head and Neck Squamous Cell Carcinoma (Deadline: 30 September 2024)
- Medical Treatment for Urological Cancers (Deadline: 30 September 2024)
- The Gene Therapy of Glioblastoma: New Targeted Approaches (Deadline: 30 September 2024)
- Disruption of Cell Signaling Pathways in Cancer: Prognostic and Treatment Perspectives (Deadline: 30 September 2024)
- Advances in Skin Cancer: Diagnosis, Treatment and Prognosis (Deadline: 30 September 2024)
- Glioblastoma: Recent Advances and Challenges (Deadline: 30 September 2024)
- Cancer Stem Cells and Targeted Therapy (Deadline: 30 September 2024)
- Advances in Invasive Breast Cancer: Treatment and Prognosis (Deadline: 30 September 2024)
- Drug Utilization, Safety and Effectiveness of Anti-Cancer Drugs for Solid Tumors: A Focus on Special Populations (Deadline: 1 October 2024)
- Current Status, Challenges and Future of Precision Medicine for Colorectal Cancer (Deadline: 1 October 2024)
- Radiotherapy in Melanoma (Deadline: 1 October 2024)
- Advances in the Management of Peritoneal Surface Malignancies (Deadline: 10 October 2024)
- Overcoming Drug Resistance to Systemic Therapy in Breast Cancer (Deadline: 15 October 2024)
- Preoperative Chemoradiotherapy for Gastrointestinal Cancer (Deadline: 15 October 2024)
- Contemporary Management for Gallbladder Cancer: From Diagnosis to Treatment (Deadline: 15 October 2024)
- Recent Advances on the Role of Intensity–Modulated Radiotherapy in Cancer (Deadline: 15 October 2024)
- Radiobiological Modelling in the New Era of Precision Radiation Oncology (Deadline: 15 October 2024)
- Neoadjuvant Immunotherapy in Genitourinary Tumors (Deadline: 20 October 2024)
- Oncology: State-of-the-Art Research in UK, 2nd Edition (Deadline: 20 October 2024)
- Radiation Therapy in Lymphoma (Deadline: 20 October 2024)
- Personalized Therapy of Hormone-Responsive Breast Cancer (Deadline: 20 October 2024)
- Recent Advances in Management of Renal Cell Carcinoma (Deadline: 20 October 2024)
- Identifying Treatment Targets for Neuroblastoma in the Era of Precision Medicine (Deadline: 22 October 2024)
- Advances in Ovarian Cancer Research and Treatment (Deadline: 24 October 2024)
- Advances in Radiotherapy for Head and Neck Cancer (Deadline: 25 October 2024)
- New and Emerging Strategies for Targeting Genomic Instability and Overcoming Drug Resistance in Lung Cancer (Deadline: 25 October 2024)
- Liver Cancer: Improving Standard Diagnosis and Therapy: 2nd Edition (Deadline: 25 October 2024)
- PI3K Pathway in Cancer (Deadline: 25 October 2024)
- Recent Advances in the Understanding of Myelodysplastic Syndrome and Acute Myeloid Leukemia (Deadline: 28 October 2024)
- What Is New in the Treatment of Intraocular (Uveal) Melanoma (Deadline: 30 October 2024)
- The Application of Laparo-Endoscopic and Robotic Surgery in Cancer Treatments and Research (Deadline: 30 October 2024)
- From Genomics and Immunogenomics to Treatments of Head and Neck Cancer (Deadline: 30 October 2024)
- Immunotherapy for Hepatocellular Carcinoma: Novel Experimental Approaches and Biomarkers (Deadline: 30 October 2024)
- Radiation Dose in Cancer Radiotherapy (Deadline: 31 October 2024)
- First-Line Therapy in Thoracic Oncology (Deadline: 31 October 2024)
- Cancer-Therapy-Related Adverse Events in Organs (Deadline: 31 October 2024)
- Curative Therapies for Non-small Cell Lung Cancer (Deadline: 31 October 2024)
- Radiotherapy and New Biological Paradigms in Cancer Treatments (Volume II) (Deadline: 31 October 2024)
- Recent Advances in Pancreatic Surgery for Pancreatic Ductal Adenocarcinoma (Deadline: 31 October 2024)
- Recent Advances in Hepatobiliary Cancers: From Diagnosis to Treatment (2nd Edition) (Deadline: 31 October 2024)
- Radiation Therapy for Pancreatic Cancer (Deadline: 31 October 2024)
- Advances in Radiation Therapy for Head and Neck Cancer (Deadline: 31 October 2024)
- Modern Surgical Treatments for Thoracic Malignancies (Deadline: 31 October 2024)
- Hematopoietic Stem Cell Transplant in Hematological Malignancies (Deadline: 31 October 2024)
- Radioligand Therapy (RLT) in Neuroendocrine Neoplasms (Deadline: 31 October 2024)
- Surgery for Cervical Cancer (Deadline: 31 October 2024)
- Prostate Cancer Therapy: Supporting Strategies and Management Options (Deadline: 31 October 2024)
- Radiation Therapy for Brain Tumors (Deadline: 31 October 2024)
- Hypofractionated Radiotherapy in Cancer Treatments (Deadline: 31 October 2024)
- Novel Targeted Therapies in Brain Tumors (Deadline: 31 October 2024)
- Discoveries in Targeted Therapies for Melanoma: From Molecular Mechanisms to Therapeutics (Deadline: 1 November 2024)
- New Insights into Urologic Oncology (Deadline: 1 November 2024)
- Triple Negative Breast Cancer Therapy Resistance and Metastasis (Deadline: 5 November 2024)
- Acute Promyelocytic Leukemia (APML) (Deadline: 5 November 2024)
- Liquid Biopsy in Cancer 2.0 (Deadline: 10 November 2024)
- Advances in Management of Urothelial Cancer (Deadline: 10 November 2024)
- Management of Pancreatic Cancer (Deadline: 15 November 2024)
- De-escalation of Axillary and Breast Cancer Surgery in the Setting of Neo-Adjuvant Chemotherapy (Deadline: 15 November 2024)
- Advances in Interventional Oncologic Therapies (Deadline: 15 November 2024)
- MRI-Guided Real-Time Adaptive Radiotherapy (Deadline: 15 November 2024)
- Contemporary Surgical Management of Melanoma (Deadline: 15 November 2024)
- Research on Early-Stage Breast Cancer: Management and Treatment (Deadline: 15 November 2024)
- Hepatobiliary Cancers: Infection, Inflammation and Therapy (Deadline: 20 November 2024)
- Immunotherapy of Solid Tumors and New Ideas of Anti-tumor Metastasis (Deadline: 20 November 2024)
- Breast Cancer and Hormone-Related Therapy (Deadline: 20 November 2024)
- Genetic Analysis and Clinical Therapy in Head and Neck Cancers (Deadline: 20 November 2024)
- Clinical Evaluation of Potential Indicators of Efficacy and Toxicity of Anticancer Therapies (Deadline: 20 November 2024)
- Diagnosis and Treatment of Cutaneous Melanoma (Deadline: 20 November 2024)
- State-of-the-Art Mechanisms of Drug Resistance to Targeted Therapy in Cancers (Deadline: 25 November 2024)
- Advances in Thoracic Oncology Research (Deadline: 25 November 2024)
- Surgical Innovations in Gynecologic Oncology: Endometrial and Ovarian Cancer (Deadline: 29 November 2024)
- Targeted Radiation Therapy and Molecular Imaging in Neuroendocrine Cancer (Deadline: 29 November 2024)
- Post-neoadjuvant Strategies in Breast Cancer (Deadline: 30 November 2024)
- Hairy Cell Leukemia and Related Disorders—Current Progress in Biology and Treatment (Deadline: 30 November 2024)
- Neo-Adjuvant Treatment of Breast Cancer (Deadline: 30 November 2024)
- Novel Targeted Therapies for T-cell Malignancies (Deadline: 30 November 2024)
- Updates in Chronic Lymphocytic Leukemia: 10 Years of Paradigm Change and Outlook for the Future (Deadline: 30 November 2024)
- Personalized Treatment Strategies for Thyroid Carcinoma (Deadline: 30 November 2024)
- Gene and Cell Therapy for Cancers (Deadline: 30 November 2024)
- Advances in Esophagogastric Cancer (Deadline: 30 November 2024)
- Gynecologic Oncology: Clinical and Translational Research (Deadline: 30 November 2024)
- Advance Research in Imaging-Guided Cancer Therapy (Deadline: 30 November 2024)
- Minimally Invasive Surgical Treatments in Kidney Cancer: Clinical Implications, Risk Assessment, and Outcomes (Deadline: 30 November 2024)
- Acute Myeloid Leukemia: From Diagnosis to Treatment (Deadline: 30 November 2024)
- Radiation Therapy for Modern Management of Bone Metastases (Deadline: 30 November 2024)
- Advancements in Image-Guided Radiotherapy for the Treatment of Lung Cancer (Deadline: 30 November 2024)
- Perioperative and Surgical Management of Gastrointestinal Cancers (Deadline: 30 November 2024)
- Radiotherapy for Thoracic Malignancies: New Advances and Challenges (Volume II) (Deadline: 30 November 2024)
- Combination Therapy in Geriatric Population with Cancer (Deadline: 30 November 2024)
- Immune Checkpoint Inhibitors, Targeted Therapies and Adjuvant Treatment of Lung Cancer (Deadline: 30 November 2024)
- Advances in Radiation Immuno-Oncology: Progress at the Interface of Radiation Oncology and Immunotherapy—A Themed Issue in Honor of Prof. Dr. Gabriele Multhoff (Deadline: 30 November 2024)
- Advanced Ovarian Cancer (Deadline: 30 November 2024)
- Artificial Cells for Use in Cancers (Deadline: 30 November 2024)
- Advancing Hepatocellular Imaging: Innovations in Diagnosis, Prognosis, and Treatment Response Assessment (Deadline: 1 December 2024)
- Advancements in Surgical Approaches for Gynecological Cancers (Deadline: 1 December 2024)
- Nuclear Receptors in the Etiology and Treatment of Cancer (Deadline: 1 December 2024)
- Surgical Treatment of Endocrine Cancer (Deadline: 1 December 2024)
- Pituitary Tumors: Molecular Insights, Diagnosis, and Targeted Therapy (2nd Edition) (Deadline: 1 December 2024)
- Imaging in Breast Cancer Diagnosis and Treatment (Deadline: 5 December 2024)
- Treatment Outcomes in Older Adults with Cancer (Deadline: 5 December 2024)
- Castration-Resistant Prostate Cancer: Progress and Promise (Deadline: 5 December 2024)
- Contemporary Treatment of Colorectal Cancer (Deadline: 10 December 2024)
- CWC2024: New Frontiers in Oncology Research and Practice (Deadline: 12 December 2024)
- Neurofibromatosis (Deadline: 15 December 2024)
- 2nd Edition: Imaging and Therapy in Lung Cancer and Mesothelioma (Deadline: 15 December 2024)
- Advances in TNBC: New Markers for Innovative Treatments (Deadline: 15 December 2024)
- Clinical Surgery for Hepato-Pancreato-Biliary (HPB) Cancer (Deadline: 15 December 2024)
- Advances in Blood Cancers: How We Define Success (Deadline: 15 December 2024)
- Genitourinary Malignancies (Deadline: 15 December 2024)
- Advances in Gynecological Oncology: From Pathogenesis to Therapy: 2nd Edition (Deadline: 18 December 2024)
- Communication and Accessibility in the Tumor Microenvironment as a Therapeutic Target (Deadline: 20 December 2024)
- Evolving Trends in the Surgical Therapy of Patients with Gynecological Cancer (Deadline: 20 December 2024)
- Thoracic Neuroendocrine Tumors and the Role of Emerging Therapies (Deadline: 20 December 2024)
- Novel Therapeutic Targets and Management in Pediatric Cancer (Deadline: 20 December 2024)
- Adaptive Resistance to Targeted Cancer Therapies and Rational Development of Combination Therapies (Deadline: 20 December 2024)
- Recent Advances in Deep Learning and Medical Imaging for Cancer Treatment (Volume II) (Deadline: 20 December 2024)
- Rare Breast Tumors (Deadline: 23 December 2024)
- Pediatric Cancers: Insights and Novel Therapeutic Approaches (Deadline: 24 December 2024)
- Multimodal Treatment for Pancreatic Cancer (Deadline: 30 December 2024)
- Towards a Tailored Treatment of Chronic Lymphocytic Leukemia (Deadline: 30 December 2024)
- Radiomics in Cancer Diagnosis, Prognosis and Treatment (Deadline: 30 December 2024)
- New Insights into Kidney Disease Development and Therapy Strategies (Deadline: 31 December 2024)
- Feature Paper in Section “Cancer Therapy” in 2024 (Deadline: 31 December 2024)
- Oesogastric Cancer: Treatment and Management (Deadline: 31 December 2024)
- Advance in Treatment of Chronic Lymphocytic Leukemia (Deadline: 31 December 2024)
- Application of Human Three-Dimensional Multicellular Models for Personalized Cancer Therapy (Deadline: 31 December 2024)
- Cancer Chemotherapy: Combination with Inhibitors (2nd Edition) (Deadline: 31 December 2024)
- Combination Therapies for Brain Tumors (Deadline: 31 December 2024)
- Stereotactic Radiotherapy in Tumor Ablation (Volume II) (Deadline: 31 December 2024)
- AI-Powered New Imaging Strategies for Pediatric Brain Tumor Diagnosis (Deadline: 31 December 2024)
- Minimally Invasive Gastric Cancer Surgery (Deadline: 31 December 2024)
- Class 2 Tumor Suppressor Gene Pathways for Therapeutic Applications in Hard-to-Treat Cancers (Deadline: 31 December 2024)
- Current Progress and Research Trends in Ocular Oncology (Deadline: 31 December 2024)
- Clinical Treatment and Prognostic Factors of Urologic Cancer (Deadline: 31 December 2024)
- Benign and Malignant Neoplasms of the Head and Neck (Deadline: 31 December 2024)
- Molecular Markers and Targeted Therapy for Hepatobiliary Tumors (Deadline: 31 December 2024)
- Advances in Surgical Treatment of Urinary Tumors (Deadline: 31 December 2024)
- Rapid Diagnostics for Antimicrobial Resistance in Cancer Patients (Deadline: 31 December 2024)
- New Approaches in Radiotherapy for Cancer (Deadline: 31 December 2024)
- Pathogenesis and Treatment Strategies in Multiple Myeloma: From Basic Research to Real Life (Deadline: 31 December 2024)
- Liver Cancer: Current Surgical Management (Deadline: 31 December 2024)
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Cancer Therapy (Deadline: 31 December 2024)
- Diagnosis and Treatment for Hepatocellular Tumors (Volume II) (Deadline: 31 December 2024)
- Chemotherapy and Immunotherapy of Lung Cancer (Deadline: 31 December 2024)
- Targeted Therapies for EGFR in Non-small Cell Lung Cancer (Deadline: 31 December 2024)
- Advances in Proton Therapy for Head and Neck Cancer: Techniques, Outcomes and Planning Variations (Deadline: 31 December 2024)
- Tumor Suppressor and Targeted Therapy in Hepatocellular Carcinoma: From Diagnosis to Treatment (Deadline: 31 December 2024)
- Current Role of Ablation in Liver Cancer Therapy (Volume II) (Deadline: 31 December 2024)
- New Insights on Management of Acute Lymphoblastic Leukemia in the Contemporary Era (Deadline: 31 December 2024)
- Advances in Therapeutic Approaches Targeting Pediatric and Adult Glioma (Deadline: 31 December 2024)
- Advances in the Management of Prostate Cancer: New Insights into Biological and Clinical Factors (Deadline: 1 January 2025)
- RAS Signaling Pathway in Cancer Therapy (Deadline: 5 January 2025)
- Targeting Mechanisms of Protein Degradation for Cancer Therapy—Volume II (Deadline: 6 January 2025)
- The Genetic Analysis and Clinical Therapy in Lung Cancer (Deadline: 10 January 2025)
- New Therapeutic Strategies of Radioresistant Tumours by Radiosensitization (Deadline: 15 January 2025)
- Advances in Systemic Therapy and Radiotherapy for the Treatment of Lung Cancer (Deadline: 15 January 2025)
- Novel Therapeutic Approaches for Cancer Treatment (Deadline: 15 January 2025)
- Gastrointestinal and Its Associated Malignancies: Diagnosis, Targets and Therapies (Deadline: 15 January 2025)
- Advances in the Diagnosis and Treatment of Genitourinary Cancers (Deadline: 20 January 2025)
- New Technologies Used to Diagnose and Treat Lymphomas (Deadline: 20 January 2025)
- New Findings in Targeting Cancer Proteins (Deadline: 20 January 2025)
- New Insights into Robotic Surgery for Urologic Cancer (Deadline: 20 January 2025)
- Advances in Human-Papillomavirus-Related Squamous Cell Carcinoma: From Pathogenesis to Treatment (Deadline: 20 January 2025)
- Pancreatic Cancer Treatment: Immunotherapy, Chemotherapy, Chemoradiation, and Targeted Therapy (Deadline: 25 January 2025)
- Surgical Advances in Cancer Treatments: Exploring Innovative Approaches and Emerging Perspectives by the Italian College of Associate Professors of Surgery (Deadline: 31 January 2025)
- The Emerging Role of Ion Channels in Cancer Treatment (Deadline: 31 January 2025)
- Adjuvant Therapy for Pancreatic Cancer (Deadline: 31 January 2025)
- The Emerging Landscape of Urological Cancers: Proven Concepts, Novel Insights (Deadline: 31 January 2025)
- Metronomic Chemotherapy in Cancer Treatment (Deadline: 31 January 2025)
- Advances in Diagnosis, Treatment and Management of Endocrine Neoplasms (Deadline: 31 January 2025)
- Current Status of Neuroendocrine Tumors with a Special Focus on Diagnosis and Novel Treatments—2nd Edition (Deadline: 31 January 2025)
- Multidisciplinary Management of Hepatocellular Carcinoma Innovations in Diagnosis, Treatment, and Prognostication (Deadline: 31 January 2025)
- Tyrosine Kinase Inhibitors (TKIs) in Cancer Targeted Therapy (2nd Edition) (Deadline: 31 January 2025)
- Surgical Management of Gastric Cancer: New Insights and Future Prospectives (Deadline: 31 January 2025)
- New Challenges in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (Deadline: 31 January 2025)
- Novel and Personalized Therapies for Multiple Myeloma and Plasma Cell Disorders (Volume II) (Deadline: 15 February 2025)
- Advances in Radiomic, Genomic and Radiogenomic Techniques in Pediatric Medulloblastoma (Deadline: 15 February 2025)
- Targeting Tumor Microenvironment in Cancer: An Impact on Therapeutic Efficacy (Deadline: 15 February 2025)
- New and Future Focused Therapies for Thyroid Cancer (Deadline: 15 February 2025)
- Rare Cancers, Diagnostic Challenges and Personalized Therapeutic Approaches in the 21st Century (Deadline: 20 February 2025)
- Gastrointestinal Cancers: Novel Diagnostic and Treatment Methods (Deadline: 20 February 2025)
- A New Era in Treatment of Early-Stage Non-small Cell Lung Cancer (Deadline: 25 February 2025)
- Advances in Castration-Resistant Prostate Cancer Treatment (Deadline: 27 February 2025)
- Recent Advances in Orthopaedic Oncology: 2nd Edition (Deadline: 28 February 2025)
- Endometrial Cancer Prevention, Early Diagnosis and Treatment: Advances and Challenges (Deadline: 28 February 2025)
- Mesothelioma—from Diagnosis to Treatment (Deadline: 28 February 2025)
- Clinical and Surgical Outcomes in the Management of Extremity Soft Tissue Sarcomas (Deadline: 28 February 2025)
- Novel Perspectives in Nasopharyngeal Carcinoma (Deadline: 28 February 2025)
- Cell Therapy in Solid Cancers: Current and Future Landscape (Deadline: 28 February 2025)
- Perioperative Management and Cancer Outcome (Deadline: 28 February 2025)
- Hematologic Malignancies and Related Disorders: Challenges from Diagnosis to Treatment (Deadline: 28 February 2025)
- Treg Cell Immunotherapy in Cancer (Deadline: 28 February 2025)
- Radioligand Therapy in Cancer (Deadline: 28 February 2025)
- Advances in the Treatment of Hepatocellular Carcinoma (Deadline: 1 March 2025)
- Early-Onset Colorectal Cancer—Updates in Screening and Treatment (Deadline: 1 March 2025)
- Overcoming Chemoresistance in Cancer: Identifying Biomarkers and Novel Targets (Deadline: 1 March 2025)
- Developments in the Management of Gastrointestinal Malignancies (Deadline: 1 March 2025)
- Surgical Advances in the Treatment of Gliomas: Preserving Function and Quality of Life (Deadline: 7 March 2025)
- New Strategies in Diagnosis and Treatments for Brain Tumors (Volume II) (Deadline: 10 March 2025)
- Recent Developments in Proton Therapy of Head and Neck Cancer (Deadline: 10 March 2025)
- Upper Tract Urothelial Carcinoma: Current Knowledge and Perspectives (Deadline: 10 March 2025)
- Advances in Ovarian Cancer Treatment: Past, Present and Future (Deadline: 15 March 2025)
- Current Status and Clinical Developments in Lung Cancer: What to Expect from Emerging Drugs? (Deadline: 15 March 2025)
- Immunotherapy and Targeted Molecular Therapy in Thoracic Surgical Oncology (Deadline: 20 March 2025)
- Involvement of RNA Polymerases I and III in Cancer Progression (Volume II) (Deadline: 21 March 2025)
- Advances in the Treatment of Upper Gastrointestinal Cancer (Deadline: 21 March 2025)
- Non-genomic Mechanism-Based Therapy against Melanoma (Deadline: 25 March 2025)
- Study on Clinical Treatment of Brain Tumors (Deadline: 28 March 2025)
- Advances in Anal Cancer (Deadline: 30 March 2025)
- The Advances in Renal Cell Carcinoma (Deadline: 31 March 2025)
- Advances in Cell and Gene Therapy in Tumors: From Bench to Bedside (Deadline: 31 March 2025)
- Targeted Therapy in Gastrointestinal Cancer (Deadline: 31 March 2025)
- The Prevention and Treatment of Prostate Cancer (Deadline: 31 March 2025)
- Targeted Therapies for Pediatric Solid Tumors (2nd Edition) (Deadline: 31 March 2025)
- Advanced Research on Spine Tumor (Deadline: 31 March 2025)
- Oral Potentially Malignant Disorders and Oral Cavity Cancer (Deadline: 31 March 2025)
- Surgery for Colorectal Cancer (Deadline: 31 March 2025)
- Treatment of Abdominal Tumors (Deadline: 31 March 2025)
- Biomarkers for the Early Detection and Treatment of Cancers: 2nd Edition (Deadline: 31 March 2025)
- Novel Combinatorial Approaches for Immunotherapy and Targeted Therapies in Cancer (Deadline: 31 March 2025)
- Bridging the Gap: Integrating AI into Clinical Practice for Oncological PET/CT Imaging (Deadline: 1 April 2025)
- Targeted Therapies for B-cell Leukemia and Lymphoma (Deadline: 1 April 2025)
- Endometrial Cancer—from Diagnosis to Management (Deadline: 9 April 2025)
- Novel Therapies of Salivary Gland Cancer (Deadline: 10 April 2025)
- Signaling Pathways in Breast Cancer: 2nd Edition (Deadline: 11 April 2025)
- Updates in Neuroendocrine Neoplasms (Deadline: 15 April 2025)
- Novel Approaches to Gynecologic Cancers Biology and Treatment: 2nd Edition (Deadline: 15 April 2025)
- Advances in the Research and Treatment of Pancreatic Cancer (Deadline: 18 April 2025)
- Inflammatory Bowel Disease and Cancers (Deadline: 20 April 2025)
- Research on Early Diagnosis and Treatment of Gastric Cancer (Deadline: 25 April 2025)
- Research on Current Progress in Penile Cancer (Deadline: 25 April 2025)
- Research on Surgical Treatment for Ovarian Cancer (Deadline: 25 April 2025)
- Lung Cancer: Updates on Therapy and Efficacy/Toxicity Prediction (Deadline: 30 April 2025)
- Resection Versus Transplant for Hepatocellular Carcinoma (Deadline: 30 April 2025)
- Advances in Brachytherapy in the Treatment of Tumors (Deadline: 30 April 2025)
- Neoadjuvant Chemotherapy for Breast Cancer (Deadline: 30 April 2025)
- Novel Therapeutic Strategies in Salivary Gland Tumor (Deadline: 30 April 2025)
- Stereotactic Body Radiotherapy in Gynecologic Malignancies—a Practical Framework of SBRT, Chemoradiotherapy and Immunotherapy (Deadline: 30 April 2025)
- Advances on Imaging and Treatment of Head and Neck Cancer (Deadline: 30 April 2025)
- Precision Medicine in Lung Cancer (Deadline: 30 April 2025)
- The Latest Findings of the Comprehensive Management of Intrahepatic Hepatocellular Carcinoma through the Combined Use of Lenvatinib and Locoregional Therapies (Deadline: 1 May 2025)
- Recent Advances in Drug Delivery for Cancer Therapy (Deadline: 5 May 2025)
- Novel Surgical Treatment Approaches in Advanced Gastrointestinal Neoplasms (Deadline: 10 May 2025)
- The Current Status of Treatment for Oligometastatic Lung Cancer (Deadline: 15 May 2025)
- Molecular Alterations and Targeted Therapy in Gastric Cancer (Deadline: 15 May 2025)
- Improving Surgical Care for Patients with Hepatobiliary and Pancreatic Cancers (Deadline: 20 May 2025)
- Recent Advances in Rare Cancers: From Bench to Bedside and Back (Deadline: 20 May 2025)
- The Surgical Management of Colorectal Cancer (Deadline: 21 May 2025)
- Advances in the Management of Patients with Melanoma and Brain Metastases (Deadline: 30 May 2025)
- The Advance of Biomarker-Driven Targeted Therapies in Cancer (Deadline: 30 May 2025)
- Current Advances in Management of Neuroendocrine Neoplasms (Deadline: 30 May 2025)
- Breast Conservation and Radiotherapy in the Era of De-escalation of Breast Cancer Treatments (Deadline: 30 May 2025)
- Management of Recurrent Endometrial Cancer (Deadline: 30 May 2025)
- Navigating the Landscape of Female Cancers: Recent Discoveries and Treatment Trends (Deadline: 31 May 2025)
- Recent Advances and Challenges in Breast Cancer Surgery: 2nd Edition (Deadline: 31 May 2025)
- Head and Neck Cancer: Advanced PET/CT and MRI Imaging with a Focus on Current and Emerging Molecular Theranostics (Deadline: 31 May 2025)
- Advancements in Bladder Cancer Therapy (Deadline: 31 May 2025)
- The Neoadjuvant Therapy for Breast Cancer (Deadline: 31 May 2025)
- Neurosurgical Management of Gliomas (Deadline: 31 May 2025)
- Novel Experimental Therapeutic Targets and Strategies for Brain Tumors (Deadline: 31 May 2025)
- Treatment Options and Risk Factors of Pancreatic Neuroendocrine Neoplasms (Deadline: 31 May 2025)
- Contemporary Diagnosis and Management of Prostate Cancer (Deadline: 31 May 2025)
- Drug Delivery for Cancer Therapy (Deadline: 31 May 2025)
- New Insights into Oligo-Recurrence of Various Cancers (2nd Edition) (Deadline: 31 May 2025)
- Oncology: State-of-the-Art Research in Austria (Deadline: 31 May 2025)
- Diagnoses and Treatments of Metastatic Endometrial Cancer (Deadline: 31 May 2025)
- Photodynamic Therapy for Cancers: An Update (Deadline: 6 June 2025)
- Advances in the Multidisciplinary Management of Hepatocellular Carcinoma (Deadline: 12 June 2025)
- Advances in B-cell Lymphoma: From Diagnostics to Cure (Deadline: 15 June 2025)
- Adjuvant Therapy and Neoadjuvant Therapy for Melanoma (Deadline: 15 June 2025)
- The Advance of Pencil Beam Scanning Proton Beam Therapy in Cancers (Deadline: 20 June 2025)
- Pulmonary Nodule and Lung Cancer: Diagnosis and Clinical Treatment (Deadline: 20 June 2025)
- Advances in Abdominal Surgical Oncology and Intraperitoneal Therapies (Deadline: 30 June 2025)
- Diagnosis, Staging, and Management for Gynecologic Oncology (Deadline: 30 June 2025)
- Multidisciplinary Management of Rectal Cancer (Deadline: 30 June 2025)
- Advances in the Prevention and Treatment of Liver Cancer (Deadline: 30 June 2025)
- Cardio-Oncology: An Emerging Paradigm in Modern Medicine: 2nd Edition (Deadline: 30 June 2025)
- Management of Gastrointestinal Cancer in Elderly Patients (Deadline: 30 June 2025)
- Advance in Treatment of Uveal Melanoma (Deadline: 30 June 2025)
- Advances in PET/CT Application in Urological Cancer (Deadline: 30 June 2025)
- Local Management of Breast Cancer: The Evolving Relationship between Radiotherapy and Surgery (Deadline: 30 June 2025)
- Cervical Cancer: Clinical Feature, Trial and Management (Deadline: 30 June 2025)
- New Challenges for Gastric Cancer—Gut Microbiota, Post-eradication and Chemotherapy (Deadline: 30 June 2025)
- Advanced Prostate Cancer: From Bench to Bedside: 2nd Edition (Deadline: 30 June 2025)
- Treatment Response Biomarkers in Hepatocellular Carcinoma: From Basic Science to Clinical Validation (Deadline: 30 June 2025)
- Cutaneous T Cell Lymphomas: From Pathology to Treatment (Deadline: 30 June 2025)
- New Insights into Prostate Cancer Radiotherapy (Deadline: 1 July 2025)
- The Role of Radiotherapy, Immunotherapy and New Surgical Techniques in the Treatment of Lung Neoplasms (Deadline: 1 July 2025)
- Pediatric Brain Tumors: Symptoms, Diagnosis and Treatments (Deadline: 1 July 2025)
- Advances in Therapeutic Strategies for Prostate Cancer (Deadline: 1 July 2025)
- Breast Cancer: Tailored Rehabilitation Strategies to Address the Challenge of Survivorship Issues (Deadline: 3 July 2025)
- Challenges and Opportunities for Novel Therapeutic Strategies in Pediatric Oncology (Deadline: 6 July 2025)
- Recent Updates on Treatment of Uveal Melanoma (Deadline: 15 July 2025)
- Epigenetic Therapeutic Targets in Cancer (Deadline: 24 July 2025)
- State of the Art: Cardiothoracic Tumors (Deadline: 25 July 2025)
- Insights into Lymphoma Treatment (Deadline: 30 July 2025)
- New Insights into Thyroid Cancer Surgery (Deadline: 30 July 2025)
- Updates on Thyroid Cancer (Deadline: 30 July 2025)
- State of the Art and Novelties in Multidisciplinary Approach to Soft Tissue and Bone Sarcomas (Deadline: 30 July 2025)
- Cancer Inhibitory Receptors: Targeting Tumor Microenvironment Therapeutically (Deadline: 31 July 2025)
- Novel Diagnosis and Treatment Approaches in Pancreatic Cancer (Deadline: 31 July 2025)
- The Pathologic Diagnosis and Clinical Therapy of Neuroendocrine Tumors (Deadline: 31 July 2025)
- Thyroid Cancer: Diagnosis, Prognosis and Treatment (2nd Edition) (Deadline: 31 July 2025)
- Emerging Research in Primary Brain Tumor (Deadline: 31 July 2025)
- Novel Therapies in Metastatic Castration-Resistant Prostate Cancer (Deadline: 1 August 2025)
- Advances in Esophageal Cancer (Deadline: 15 August 2025)
- Advancements in Lung Cancer Surgical Treatment and Prognosis (Deadline: 15 August 2025)
- Advances in Neoadjuvant Therapy for Urologic Cancer (Deadline: 17 August 2025)
- Exploring Non-coding RNA Signatures in Cancer: Definitions and Implications for Diagnosis and Therapy (Deadline: 20 August 2025)
- Understanding the Molecular Basis and Immunobiology of Renal Cell Carcinoma and Exploring Novel Therapeutic Strategies (Deadline: 30 August 2025)
- Chemo-Radio-Immunotherapy for Colorectal Cancer (Deadline: 30 August 2025)
- Modern Approach to Oral Cancer (Deadline: 30 August 2025)
- Emerging Therapies in the Management of Gastrointestinal Malignancies (2nd Edition) (Deadline: 31 August 2025)
- Radiosurgery for Brain Tumors (Deadline: 31 August 2025)
- Updates on Urologic Oncology: From Diagnosis to Localized and Systemic Therapy Options (2nd Edition) (Deadline: 31 August 2025)
- Role of BCL-2 Family Proteins in Cancer: Therapeutic Advancements and Challenges (Deadline: 31 August 2025)
- Advancing Horizons in Colorectal Surgery: Innovative Approaches and Outcomes (Deadline: 31 August 2025)
- New Perspectives in the Treatment of Thoracic Cancers (Deadline: 1 September 2025)
- Targeting RNA to Improve Cancer Precision Medicine (Deadline: 30 September 2025)
- Prognosis and Treatment of Cutaneous Melanoma (2nd Edition) (Deadline: 31 October 2025)
- Gastrointestinal Cancer Surgery (Deadline: 31 October 2025)
- Mesothelioma: Diagnosis and Therapy (Deadline: 30 November 2025)
- New Approaches in the Treatment of Hepatocellular Carcinoma and Liver Tumor (Deadline: 30 November 2025)
- The Applications of Artificial Intelligence in Gastroenterology (Deadline: 31 December 2025)
- Surgical Aspects of Ovarian/Tubal/Peritoneal Cancer Management (Deadline: 31 December 2025)
- New Perspectives in the Management of Breast Cancer (Deadline: 31 December 2025)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Advances in Diagnostics and Treatment of Head and Neck Cancer
- Advances in Multiple Myeloma Research and Treatment
- Advances in the Management of Hepatocellular Carcinoma
- Breast Cancer: From Pathophysiology to Prevention and Treatment (Closed)
- Breast Cancer—Therapeutic Challenges, Research Strategies and Novel Diagnostics
- Cancer Nanomedicine
- Combination Therapies in Cancers
- Emerging Therapeutics in Advanced Melanoma
- Hyperthermia in Cancer Therapy
- Ion Channels in Cancer Therapies
- Neuroendocrine Tumors: Treatment and Management
- New Treatment for Colorectal Cancer
- Oncology: State-of-the-Art Research in the USA
- Particle Therapy: State-of-the-Art and Future Prospects
- Treatment of Glioma
- Treatment of Hepatocellular Carcinoma and Cholangiocarcinoma
- Urological Cancer